LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics

doi:10.4254/wjh.v12.i6.298

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 12, Issue 6

This Article

(264)

(312)

(0)

(8)

(1)

(6171)

(5)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

- Full Article with Cover (PDF)
- Full Article (XML)

Retrospective Cohort Study

World J Hepatol. Jun 27, 2020; 12(6): 298-311
Published online Jun 27, 2020. doi: 10.4254/wjh.v12.i6.298

Table 4 Validation cohort characteristics

Factor	Training cohort (n = 436)		Validation cohort A (n = 336)		P value
Factor	n	Statistics	n	Statistics	P value
Gender	436		336		< 0.030²
Female		151 (34.6)		142 (42.3)
Male		285 (65.4)		194 (57.7)
Serum bilirubin	435	4.2 (2.0, 10.4)	336	5.0 (2.0, 13.5)	< 0.26¹
PT	436	16.8 (14.2, 20.7)	336	18.0 (14.8, 23.5)	< 0.003¹
WBC	436	7.5 (5.0, 11.4)	336	8.3 (5.0, 14.0)	< 0.040¹
MAP	436	65.0 (56.0, 106.0)	336	64.0 (56.0, 75.0)	< 0.26¹
Non-liver specific scores
APACHE III	435	83.0 (65.0, 102.0)	333	88.0 (70.0, 109.0)	< 0.006¹
SOFA	263	10.0 (8.0, 12.0)	186	11.0 (8.0, 14.0)	< 0.003¹
Liver specific scores
MELD	435	22.0 (16.0, 30.0)	336	25.0 (17.0, 33.0)	< 0.004¹
MELD-Na	435	24.0 (18.0, 31.0)	336	27.0 (20.0, 34.0)	< 0.006¹
CLIF-SOFA	262	11.0 (9.0, 13.0)	336	11.0 (9.0, 13.0)	< 0.53¹
RFH	259	0.05 (-0.77, 1.1)	184	0.83 (-0.18, 2.1)	< 0.001¹
LIV-4	435	16.8 (5.7, 43.6)	336	23.0 (7.1, 57.7)	< 0.007¹
Admission outcomes
ICU LOS (d)	436	2.6 (1.4, 5.2)	336	3.7 (2.0, 7.6)	< 0.001¹
Hospital LOS (d)	436	8.7 (4.7, 16.8)	336	11.7 (5.7, 22.0)	< 0.002¹
Hospital discharge status	436		336		< 0.17²
Discharged alive		317 (72.7)		229 (68.2)
In-hospital death		119 (27.3)		107 (31.8)

¹Kruskal-Wallis test.

²Pearson’s χ² test. PT: Prothrombin time; WBC: White blood cell count; MAP: Mean Arterial Pressure; APACHE: Acute physiology and chronic health evaluation; SOFA: Sequential (or Sepsis-related) organ failure assessment; MELD: Model for end-stage liver disease; Na: Sodium; CLIF-SOFA: Chronic liver failure-sequential organ failure assessment; RFH: Royal Free Hospital; LOS: Length of stay.

Full Size Table

Citation: Lindenmeyer CC, Flocco G, Sanghi V, Lopez R, Kim AJ, Niyazi F, Mehta NA, Kapoor A, Carey WD, Mireles-Cabodevila E, Romero-Marrero C. LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics. World J Hepatol 2020; 12(6): 298-311
URL: https://www.wjgnet.com/1948-5182/full/v12/i6/298.htm
DOI: https://dx.doi.org/10.4254/wjh.v12.i6.298

Lindenmeyer CC, Flocco G, Sanghi V, Lopez R, Kim AJ, Niyazi F, Mehta NA, Kapoor A, Carey WD, Mireles-Cabodevila E, Romero-Marrero C. LIV-4: A novel model for predicting transplant-free survival in critically ill cirrhotics. World J Hepatol 2020; 12(6): 298-311 [PMID: 32742572 DOI: 10.4254/wjh.v12.i6.298]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.